IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression

Journal of Immunology

Volumn 163, Issue 2, 1999, Pages 920-926

  Sedger, Lisa M ^a   Shows, Donna M ^a   Blanton, Rebecca A ^a   Peschon, Jacques J ^a   Goodwin, Ray G ^a   Cosman, David ^a   Wiley, Steven R ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIGAND; TUMOR NECROSIS FACTOR ALPHA;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CELL KILLING; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS REPLICATION;

ADJUVANTS, IMMUNOLOGIC; ANTIVIRAL AGENTS; APOPTOSIS REGULATORY PROTEINS; CELL DEATH; CELLS, CULTURED; CYTOKINES; CYTOMEGALOVIRUS; DRUG SYNERGISM; FIBROBLASTS; HUMANS; INTERFERON TYPE II; MEMBRANE GLYCOPROTEINS; NF-KAPPA B; RECEPTORS, TUMOR NECROSIS FACTOR; RNA, MESSENGER; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA; VIRUS REPLICATION;

EID: 0033565590     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Boehm, U., T. Klamp, M. Groot, and J. C. Howard. 1997. Cellular responses to interferon-γ. Annu. Rev. Immunol. 15:749.
2. Samuel, C. E. 1991. Antiviral actions of interferon: interferon-regulated cellular proteins, and their surprising selective antiviral activities. Virology 183:1.
3. Murphy, M., B. Perussia, and G. Trinchieri. 1988. Effects of recombinant tumor necrosis factor, lymphotoxin, and immune interferon on proliferation and differentiation of enriched hematopoietic precursors cells. Exp. Hematol. 16:131.
4. + T cells in persistent infection with lymphocytic choriomeningitis virus. J. Exp. Med. 187:1903.
5. + human marrow cells in induced by interferon-γ and tumor necrosis-α and potentiated cytokine mediated haematopoietic suppression in vitro. Blood 85:3183.
6. Munn, D. H., A. C. Beall, D. Song, R. W. Wrenn, and D. C. Throckmorton. 1995. Activation-induced apoptosis in human macrophages: developmental regulation of a novel cell death pathway by macrophage colony-stimulating factor and interferon-γ. J. Exp. Med. 181:127.
7. Valete, G., L. Ozman, F. Novelli, M. Geuna, G. Palestro, G. Forni, and G. Garotta. 1992. Distribution of interferon receptors in human tissues. Eur. J. Immunol. 22:2403.
8. Wiley, S. R., K. Schooley, P. J. Smolack, W. S. Din, C.-P. Huang, J. K. Nicholl, G. R. Sutherland, T. Davis-Smith, C. Rauch, C. A. Smith, et al. 1995. Identification and characterization of a new member of the TNF family that induces apoplosis. Immunity 3:673.
9. Pan, G., K. O'Rourke, A. M. Chinnaiyan, R. Gentz, R. Ebner, J. Ni, and V. M. Dixit. 1997. The receptor for the cytotoxic ligand TRAIL. Science 276: 111.
10. Walczak, H., M. A. Degli-Esposti, R. S. Johnson, P. J. Smolak, J. Y. Waugh, N, Boiani, M. S. Timour, M. J. Gerhart, K. A. Schooley, C. A. Smith, et al. 1997. TRAIL-R2: a novel apoptosis-mediating receptor for TRAIL. EMBO J. 16:5386.
11. Pan, G., Y. F. Wei, G. Yu, R. Gentz, and V. M. Dixit. 1997. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815.
12. Screaton, G. R., J. Monkolsapaya, X. N. Xu, A. E. Cowper, A. McMichael, and J. I. Bell. 1997. TRICK2, a new alternatively spliced receptor that transduces the cytotoxic signal from TRAIL. Curr. Biol. 7:693.
13. Schneider, P., J. L. Bodmer, M. Thome, K. Hofmann, N. Holler, and J. Tschopp. 1997. Characterization of two receptors for TRAIL. FEBS Lett. 416:329.
14. MacFarlane, M., M. Ahmad, S. M. Srinivasula, T. Fernandes-Alnemri, G. M. Cohen, and E. S. Alnemri. 1997. Identification and molecular cloning of two novel receptors for the cytotoxic ligand TRAIL. J. Biol. Chem. 272:25417.
15. Sheridan, J. P., S. A. Marsters, R. M. Pitti, A. Gurney, M. Skubatch, D. Baldwin, L. Ramakrishnan, C. L. Gray, K. Baker, W. I. Wood, et al. 1997. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818.
16. Miller, D. K. 1997. The role of caspase family of cysteine proteases in apoptosis. Semin. Immunol. 9:35.
17. Ashkenazi, A., and V. M. Dixit. 1998. Death receptors: signaling and modulation. Science 281:1305.
18. Degli-Esposti, M. A., P. J. Smolak, H. Walczak, J. Waugh, C. P. Huang, R. F. DuBose, R. G. Goodwin, and C. A. Smith. 1997. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J. Exp. Med. 186:1165.
19. Degli-Esposti, M. A., W. C. Dougall, P. J. Smolak, J. Y. Waugh, C. A. Smith, and R. G. Goodwin. 1997. The novel receptor TRAIL-R4 induces NF-κB and protects against TRAIL-medialed apoptosis, yet retains an incomplete death domain. Immunity 7:813.
20. Marsters, S. A., J. P. Sheridan, R. M. Pitti, A. D. Huang, A. D. Skubatch, A. D. Baldwin, A. D. Yuang, A. D. Gurney, and A. D. Goddard. 1997. A novel receptor for Apo2L/TRAIL contains a truncated death domain. Curr. Biol. 7:1003.
21. Pan, G., J. Ni, G. Yu, Y. F. Wei, and V. M. Dixit. 1998. TRUNDD, a new member of the TRAIL receptor family that antagonizes TRAIL signaling. FEBS Lett. 6:41.
22. Schneider, P., M. Thome, K. Burns, J.-L. Bodmer, K. Hofmann, T. Kataoka, N. Holler, and J. Tschopp. 1997. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependant apoptosis and activate NFκB. Immunity 7:831.
23. Meinl, E., H. Fickenscher, M. Thome, J. Tschopp, and B. Fleckenstein. 1998. Anti-apoptotic strategies of lymphotropic viruses. Immunol. Today 19:474.
24. Barry, M., and G. McFadden. 1998. Apoptosis regulators from DNA viruses. Curr. Opin. Immunol. 10:422.
25. Kieff, E., and T. Shenk. 1998. Modulation of apoptosis by herpesviruses. Semin. Virol. 8:471.
26. Heinkelein, M., S. Pilz, and C. Jassoy. 1996. Inhibition of CD95 (Fas/Apo1)-mediated apoptosis by vaccinia virus WR. Clin. Exp. Immunol. 103:8.
27. Macen, J. L., K. A. Graham, S. F. Lee, M. Schreiber, L. K. Boshkov, and G. McFadden. 1996. Expression of the myxoma virus tumor necrosis factor receptor homologue and M11L genes is required to prevent virus-induced apoptosis in infected rabbit T lymphocytes. Virology 218:232.
28. Upton, C., J. L. Macen, M. Schreiber, and G. McFadden. 1991. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184:370.
29. Walczak, H., R. E. Miller, T. S. Griffith, K. Ariail, M. Kubin, W. Chin, J. Jones, A. Woodward, C. A. Smith, P. Smolak, et al. 1999. Tumoricidal activity of TRAIL in vivo. Nat. Med. 5:157.
30. Griffith, T. S., C. T. Rauch, P. Smolak, J. Y. Waugh, N. Boiani, D. H. Lynch, C. A. Smith, R. G. Goodwin, and M. Z. Kubin. 1999. Functional analysis of TRAIL receptors using monoclonal antibodies. J. Immunol. 162:2597.
31. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohm, A. Moller, H. Jacobsen, and H. Kirchner. 1986. Anti-viral effects of recombinant tumor necrosis factor in vitro. Nature 323:816.
32. Wong, G. H., and D. V. Goeddel. 1986. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323:819.
33. Hess, S., A. Rensing-Ehl, R. Schwabe, P. Bufler, and H. Engelmann. 1995. CD40 function in nonhemopoietic cells: NF-κB mobilization and induction of IL-6 production. J. Immunol. 155:4588.
34. Fries, K. M., G. D. Sempowski, A. A. Gaspari, T. Blieden, R. J. Looney, and R. P. Phipps. 1995. CD40 expression by human fibroblasts. Clin. Immunol. Immunopathol. 77:42.
35. Gura, T. 1997. How TRAIL kills cancer cells, but not normal cells. Science 277:768.
36. Griffith, T. S., W. Chin, G. Jackson, D. H. Lynch, and M. Kubin. 1998. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J. Immunol. 161:2833.
37. Irmler, M., M. Thome, M. Hahne, P. Schneider, K. Hofman, V. Steiner, J. L. Bodmer, M. Schroter, K. Burne, C. Mattman, et al. 1997. Inhibition of death receptor signals by cellular FLIP. Nature 388:190.
38. Jeremias, I., C. Kupatt, B. Baumann, T. Wirth, and K. M. Debatin. 1998. Inhibition of nuclear factor κB activation attenuated apoptosis resistance in lymphoid cells. Blood 91:4624.
39. Lin, S.-C., H. H. Wortis, and J. Stavnezer. 1998. The ability of CD40L, but not LPS, to initiate immunoglobulin switching to immunoglobulin G1 is explained by differential induction of NFκB/Rel proteins. Mol. Cell. Biol. 18:5523.
40. Griffith, T. S., S. R. Wiley, M. Z. Kubin, L. M. Sedger, C. Malizewski, and N. Fanger. 1999. TRAIL-mediated tumoricidal activity by human monocytes. J. Exp. Med. 189:1343.
41. Zamai, L., M. Ahmad, I. M. Bennett, L. Azzoni, E. S. Alnemri, and B. Perussia. 1998. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188:2375.
42. Katsikis, P. D., M. E. Garcia-Ojeda, J. F. Torres-Roca, I. M. Tijoe, C. A. Smith, L. A. Herzenberg, and L. A. Herzenberg. 1997. Interleukin-1β-converting enzyme-like protease involved in Fas-induced and activation-induced peripheral blood T cell apoptosis in HIV infection: TNF-related apoptosis-inducing ligand can mediate activation-induced T cell death in HIV infection. J. Exp. Med. 186:1365.